Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto


   0 (0%) 09-28 21:19
Open: Pre. Close:
High: Low:
Volume: 0 Market Cap: 0(M)

Technical analysis

as of: 2023-09-28 4:50:06 PM
Short-term rate:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Mid-term rate:       
Target: Six months: 17.61     One year: 20.57
Support: Support1: 13.9    Support2: 13.18
Resistance: Resistance1: 15.07    Resistance2: 17.61
Pivot: 13.84
Moving Average: MA(5): 14.24     MA(20): 13.91
MA(100): 13.2     MA(250): 11.92
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 90.4     %D(3): 77.5
RSI: RSI(14): 62.1
52-week: High: 15.11  Low: 9.42
Average Vol(K): 3-Month: 1,723 (K)  10-Days: 1,548 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ DVAX ] has closed Bollinger Bands are 9.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.83 - 14.88 14.88 - 14.93
Low: 14.34 - 14.41 14.41 - 14.47
Close: 14.65 - 14.75 14.75 - 14.83

Company Description

Headline News

Thu, 28 Sep 2023
Can Dynavax Technologies Corp (DVAX) Stock Rise to the Top of Healthcare Sector Thursday? - InvestorsObserver

Thu, 28 Sep 2023
Crinetics (CRNX) Stock Surges 70% in a Month: Here's Why - Nasdaq

Thu, 28 Sep 2023
Viatris (VTRS) Gets FDA Nod for Pupil Dilation Reversal Agent - Nasdaq

Wed, 27 Sep 2023
Immunovant (IMVT) Soars on Upbeat Initial IMVT-1402 Study Data - Nasdaq

Tue, 26 Sep 2023
Unveiling Dynavax Technologies (DVAX)'s Value: Is It Really Priced ... -

Tue, 26 Sep 2023
Novo Nordisk (NVO), Valo Ink Deal to Develop Heart Disease Drugs - Nasdaq

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. 129 (M)
Shares Float 122 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 100.5 (%)
Shares Short 14,030 (K)
Shares Short P.Month 17,020 (K)

Stock Financials

EPS 0.74
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.48
Profit Margin (%) 24
Operating Margin (%) 28.9
Return on Assets (ttm) 8.4
Return on Equity (ttm) 22.1
Qtrly Rev. Growth -76.5
Gross Profit (p.s.) 3.47
Sales Per Share 3.56
EBITDA (p.s.) 1.06
Qtrly Earnings Growth -97
Operating Cash Flow 152 (M)
Levered Free Cash Flow 138 (M)

Stock Valuations

PE Ratio 19.94
PEG Ratio 0
Price to Book value 3.29
Price to Sales 4.13
Price to Cash Flow 12.49

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.